Michael Nazarian is a cultivator and breeder of cannabis. He serves as CEO of GenCann, a cannabis genetics company focused on efficacy for consumers along with instituting organic methodologies and quantitative testing analyses. Michael is also the co-founder of the first published patents of THCv-dominant chemotyped cannabis cultivars.